RxDoctor Payments Data

Adry Snow, APRN

Family · McMinnville, TNNPI 1346915410

Payments from drug & device makers

$1,078in general payments, 2019–2025

Across 58 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$243
  • Otsuka America Pharmaceutical, Inc.$127
  • AstraZeneca$104
  • Boehringer Ingelheim$94
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$82
  • Novo Nordisk$69
  • plus $358 from 12 others

What the payments were for

  • Food & beverage$1,078100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,078 in reported general payments places this provider in the 65th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$468
Medicare patients
19
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide36$34,587
RybelsusSemaglutide21$24,624
EliquisApixaban15$13,992
FarxigaDapagliflozin Propanediol23$13,964
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$13,418
JardianceEmpagliflozin19$12,832
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,702
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,544
Tresiba Flextouch U-100Insulin Degludec13$5,656
Albuterol Sulfate HfaAlbuterol Sulfate105$2,174
Ventolin HfaAlbuterol Sulfate16$1,657
Atorvastatin Calcium131$1,356
Rosuvastatin Calcium73$960
Potassium Chloride56$787
Losartan Potassium63$769

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$69$59,21257 claims
AstraZenecaFarxiga, Breztri Aerosphere$104$23,66638 claims
Boehringer IngelheimJardiance$94$12,83219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 6,706 family providers in Tennessee.

Other family in McMinnville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →